IPSIndian Journal of Pharmacology
Home  IPS  Feedback Subscribe Top cited articles Login 
Users Online : 750 
Small font sizeDefault font sizeIncrease font size
Navigate Here
  »   My Preferences 
  »   Manuscript submission

 


This article has been cited by
1Drug safety and adverse drug reaction reporting behavior related to outpatient opioid replacement therapy: Results from a survey among physicians
Maximilian Gahr,Jonas Eller,Maurice Cabanis,Christoph Hiemke,Roland W. Freudenmann,Bernhard J. Connemann,Dirk Lang,Carlos Schönfeldt-Lecuona
Journal of Substance Abuse Treatment.2017;74()7
[DOI]
2Filling quality of the reports of adverse drug reactions received at the Pharmacovigilance Centre of São Paulo (Brazil): missing information hinders the analysis of suspected associations
Adalton Ribeiro,Silvana Lima,Maria-Elisa Zampieri,Mirtes Peinado,Albert Figueras
Expert Opinion on Drug Safety.2017;16(12)1329
[DOI]
3A national approach to pharmacovigilance: The case of India as a growing hub of global clinical trials
Swapnil Dylan Fernandes,Narayanan V. Anoop,Lovely Joylen Castelino,R. Narayana Charyulu
Research in Social and Administrative Pharmacy.2019;15(1)109
[DOI]
4Effectiveness of a self-instructional module on knowledge, attitude, and practice regarding pharmacovigilance among staff nurses
Sudeshna Banerjee,Sumity Arora,Gigi John,Siddhartha Dutta,Raminder Kalra,Rita Sapra
Current Medicine Research and Practice.2019;9(3)93
[DOI]
5The quality of spontaneous adverse drug reaction reports from the pharmacovigilance centre in western China
Rui Niu,Yufang Xiang,Tingting Wu,Zhi Zhang,Yue Chen,Bianling Feng
Expert Opinion on Drug Safety.2019;18(1)51
[DOI]
6Health Professionals' Knowledge, Attitudes and Practices about Pharmacovigilance in India: A Systematic Review and Meta-Analysis
Akshaya Srikanth Bhagavathula,Asim Ahmed Elnour,Shazia Qasim Jamshed,Abdulla Shehab,Nerges Mistry
PLOS ONE.2016;11(3)e0152221
[DOI]
7An overview of the pharmacovigilance system in India
Niti Mittal,Rakesh Mittal,M. C. Gupta
Clinical Research and Regulatory Affairs.2016;33(1)4
[DOI]
8Pharmacovigilance in India in Comparison With the USA and European Union: Challenges and Perspectives
Jobin Jose,Naziya Refi Rafeek
Therapeutic Innovation & Regulatory Science.2018;33(1)216847901881277
[DOI]
9A Retrospective Review of Serious Adverse Drug Reaction Reports in the Nigerian VigiFlow Database from September 2004 to December 2016
Comfort Kunak Ogar,Abiodun Abiola,Daniel Yuah,Ali Ibrahim,Ibrahim Adekunle Oreagba,Emmanuel C. Amadi,Mojisola Christianah Adeyeye,Kazeem Adeola Oshikoya
Pharmaceutical Medicine.2019;33(2)145
[DOI]
10Effect of Educational Interventions on Adverse Drug Reaction Reporting in a Cancer Institute in Japan: A Questionnaire Study
Masami Tsuchiya,Akihisa Esashi,Taku Obara,Kyoko Inooka,Nariyasu Mano,Chizuko Takamura
Hospital Pharmacy.2019;54(2)93
[DOI]
11Mobile application an approach to enhance easy adverse drug reactions reporting in India
Sachin Kuchya,Vivekanandan Kalaiselvan,Ismeet Kaur,G. N. Singh
Health and Technology.2016;6(2)157
[DOI]
12Computational drug repositioning based on side-effects mined from social media
Timothy Nugent,Vassilis Plachouras,Jochen L. Leidner
PeerJ Computer Science.2016;2(2)e46
[DOI]
13Pharmacovigilance in Russia: current state of affairs, challenges, and prospects
Geliya Gildeeva,Andrey Belostotsky
Current Medical Research and Opinion.2017;33(12)2161
[DOI]
14Reporting of adverse drug reactions in India: A review of the current scenario, obstacles and possible solutions
Rubina Mulchandani,Ashish Kumar Kakkar
International Journal of Risk & Safety in Medicine.2018;30(1)33
[DOI]
Site Map | Home | Contact Us | Feedback | Copyright and Disclaimer
Online since 20th July '04
Published by Wolters Kluwer - Medknow